Comparison of the Performance of 2 GFR Estimating Equations Using Creatinine and Cystatin C to Predict Adverse Outcomes in Elderly Individuals Insa E.

Slides:

Advertisements

Similar presentations

Michael J. Koren, MD, Michael H. Davidson, MD, Daniel J

Advertisements

Fredrik Karlsson, MD, Angelo Modica, MD, Thomas Mooe, MD, PhD

Association Between Cardiac Biomarkers and the Development of ESRD in Patients With Type 2 Diabetes Mellitus, Anemia, and CKD Akshay S. Desai, MD, MPH,

Differential Estimation of CKD Using Creatinine- Versus Cystatin C–Based Estimating Equations by Category of Body Mass Index Suma Vupputuri, PhD, Caroline.

Cystatin C and Albuminuria as Risk Factors for Development of CKD Stage 3: The Multi- Ethnic Study of Atherosclerosis (MESA) Shani Shastri, MD, MS, Ronit.

Shoshana H. Ballew, PhD, Yan Chen, BS, Natalie R. Daya, MPH, Job G

Peritoneal dialysis American Journal of Kidney Diseases

Estimating GFR Using the CKD Epidemiology Collaboration (CKD-EPI) Creatinine Equation: More Accurate GFR Estimates, Lower CKD Prevalence Estimates, and.

Olivier Niel, MD, PhD, Charlotte Boussard, MSc, Paul Bastard, MSc

Metabolic Complications in Elderly Adults With CKD

Hypertension in the hemodialysis patient and the “lag phenomenon”: insights into pathophysiology and clinical management Uday M Khosla, MD, Richard J.

Francesca Mallamaci, MD, Giovanni Tripepi, PhD

Risk of ESRD and Mortality in Kidney and Bladder Stone Formers

A Decade After the KDOQI CKD Guidelines

Comparison of the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) Study Equations: Risk Factors for and Complications.

The predictive value of s-cystatin C for mortality after coronary artery bypass surgery Alain Dardashti, MD, PhD, Shahab Nozohoor, MD, PhD, Lars Algotsson,

Blood Lead Levels and Decreased Kidney Function in a Population-Based Cohort Florencia Harari, Gerd Sallsten, Anders Christensson, Marinka Petkovic, Bo.

Risk of Venous Thromboembolism in Patients by Albuminuria and Estimated GFR David Massicotte-Azarniouch, MD, Anan Bader Eddeen, MSc, Alejandro LazoLanger,

Cardiovascular Disease and CKD: Core Curriculum 2010

Impact of Comorbidities on Mortality in Managed Care Patients With CKD

Risk Factors for ESRD in Individuals With Preserved Estimated GFR With and Without Albuminuria: Results From the Kidney Early Evaluation Program (KEEP)

Blood Lead Levels and Decreased Kidney Function in a Population-Based Cohort Florencia Harari, Gerd Sallsten, Anders Christensson, Marinka Petkovic, Bo.

A New Clinical Prediction Tool for 5-Year Kidney Transplant Outcome

Evaluation of the Potential Living Kidney Donor

Interaction of Physical Activity and Body Mass Index on Mortality in Coronary Heart Disease: Data from the Nord-Trøndelag Health Study Trine Moholdt,

Your Kidneys May Outlive You

Cystatin C Versus Creatinine for GFR Estimation in CKD Due to Heart Failure Delphine Kervella, MD, Sandrine Lemoine, MD, PhD, Florence Sens, MD, Laurence.

Focusing on Health Literacy Might Help Us Cross the Quality Chasm

Daniel E. Weiner, MD, MS American Journal of Kidney Diseases

Salt and Hypertension American Journal of Kidney Diseases

Association of Waist Circumference and Body Mass Index With All-Cause Mortality in CKD: The REGARDS (Reasons for Geographic and Racial Differences in.

Guidelines for the Older Adult With CKD

Lifetime Incidence of CKD Stages 3-5 in the United States

Baseline Kidney Function as Predictor of Mortality and Kidney Disease Progression in HIV-Positive Patients Fowzia Ibrahim, MSc, Lisa Hamzah, MRCP, Rachael.

The Kidney Early Evaluation Program (KEEP): Program Design and Demographic Characteristics of the Population Claudine T. Jurkovitz, MD, MPH, Yang Qiu,

Hemoglobin Level and Transfusions in Patients on Maintenance Dialysis: Where the Rubber Meets the Road Eduardo Lacson, MD, MPH, Franklin Maddux, MD

Management of Heart Failure in Advancing CKD: Core Curriculum 2018

Effect of Intensive Insulin Therapy and Pentastarch Resuscitation on Acute Kidney Injury in Severe Sepsis George Thomas, MD, MPH, Ethan M. Balk, MD,

David C. Mendelssohn, MD, FRCPC, Jay B. Wish, MD

CKD in Aboriginal Australians

Usability Testing and Acceptance of an Electronic Medication Inquiry System for CKD Patients Clarissa J. Diamantidis, MD, MHS, Marni Zuckerman, MA, Wanda.

Julie A. Wright Nunes, MD, MPH, Kerri L

Hypertension in the hemodialysis patient and the “lag phenomenon”: insights into pathophysiology and clinical management Uday M Khosla, MD, Richard J.

A Decade After the KDOQI CKD Guidelines: A Perspective From Mexico

Michael F. Flessner, MD, PhD, Sharon B. Wyatt, PhD, Ermeg L

Performance of GFR Estimating Equations Stratified by Measured or Estimated GFR: Implications for Interpretation Jonas Björk, PhD, Anders Grubb, MD,

Beef Tea, Vitality, Creatinine, and the Estimated GFR

Christina L. Klein, MD, Daniel C. Brennan, MD, FACP

Quiz Page April 2008 American Journal of Kidney Diseases

Study Designs in Patient-Oriented Research

Impact of Diabetes Mellitus on the Association of Vascular Disease Before Transplantation With Long-term Transplant and Patient Outcomes After Kidney.

Evidence and Outcomes in CKD

Within-Person Variability in Kidney Measures

Drug Dose Adjustments in Patients With Renal Impairment

Dennis G. Moledina, MD, Mark A. Perazella, MD

Daniel T. Lackland, DrPH, David J.P. Barker, MD, PhD

Peter A. McCullough, MD, MPH, Christopher T. Chan, MD, Eric D

Long-term Outcomes of Acute Kidney Injury: The Power and Pitfalls of Observational/Population-Based Studies Charuhas V. Thakar, MD American Journal.

Lesley A. Stevens, MD, MS, Josef Coresh, MD, PhD, Andrew S. Levey, MD

Hypertension and CKD: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES), Madhav V. Rao,

Was It the Nephrologists or the Fluid?

Achieving Fairness in Access to Kidney Transplant: A Work in Progress

James F. Winchester, MD, Thomas H. Hostetter, MD, Timothy W. Meyer, MD

Shoshana H. Ballew, PhD, Yan Chen, BS, Natalie R. Daya, MPH, Job G

Dialysis Research and N-of-1 Trials: Made for Each Other?

Racial and Ethnic Differences in Albuminuria in Individuals With Estimated GFR Greater Than 60 mL/min/1.73 m2: Results From the Kidney Early Evaluation.

Association of Low Birth Weight With Childhood Proteinuria at Age 3 Years: A Population-Based Retrospective Cohort Study Maki Shinzawa, MD, PhD, Shiro.

Clinical Practice Guidelines for Peritoneal Dialysis Adequacy

Update on Cystatin C: Incorporation Into Clinical Practice

Jacob J.E. Koopman, MD, PhD American Journal of Kidney Diseases

Presentation transcript:

Comparison of the Performance of 2 GFR Estimating Equations Using Creatinine and Cystatin C to Predict Adverse Outcomes in Elderly Individuals Insa E. Emrich, John W. Pickering, PhD, Ben Schöttker, PhD, Claudia S. Lennartz, Kyrill S. Rogacev, MD, Hermann Brenner, MD, Dietrich Rothenbacher, MD, Bernd Holleczek, PhD, Kai-Uwe Saum, MPH, Danilo Fliser, MD, Gunnar H. Heine, MD American Journal of Kidney Diseases Volume 65, Issue 4, Pages 636-638 (April 2015) DOI: 10.1053/j.ajkd.2014.12.006 Copyright © 2015 National Kidney Foundation, Inc. Terms and Conditions

Figure 1 Hazard ratio (HR) and 95% confidence interval for all-cause mortality and confusion matrices for reclassification from CKD-EPIcr-cys to BIS2 for individuals with and without the primary end point (all-cause mortality). HR1: unadjusted model; HR2: adjusted for age and sex; HR3: adjusted for age, sex, smoking, diabetes, hypertension, and BMI. Because of the small number of patients with events in eGFR category 4, categories 3b and 4 were combined. Abbreviation: NA, not available (no patients in this category). American Journal of Kidney Diseases 2015 65, 636-638DOI: (10.1053/j.ajkd.2014.12.006) Copyright © 2015 National Kidney Foundation, Inc. Terms and Conditions